Unpacking the Latest Options Trading Trends in Merck & Co
Unpacking the Latest Options Trading Trends in Merck & Co
High-rolling investors have positioned themselves bearish on Merck & Co (NYSE:MRK), and it's important for retail traders to take note.\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in MRK often signals that someone has privileged information.
高風險投資者對默沙東(紐交所:MRK)採取了看淡的立場,零售交易者應予以關注。\這一活動通過Benzinga對公開可用的期權數據的跟蹤引起了我們的注意。這些投資者的身份尚不確定,但在MRK發生如此重大變動時,往往意味着有人掌握了內部信息。
Today, Benzinga's options scanner spotted 8 options trades for Merck & Co. This is not a typical pattern.
今天,Benzinga的期權掃描儀發現了8筆默沙東的期權交易。這不是一個典型的模式。
The sentiment among these major traders is split, with 12% bullish and 50% bearish. Among all the options we identified, there was one put, amounting to $30,498, and 7 calls, totaling $404,215.
這些主要交易者的情緒各不相同,其中12%看好,50%看淡。在我們識別的所有期權中,有一筆看跌期權,金額爲30,498美元,以及7筆看漲期權,合計404,215美元。
What's The Price Target?
價格目標是什麼?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $50.0 to $115.0 for Merck & Co over the last 3 months.
考慮到這些合約的成交量和未平倉合約,看來過去3個月中,鯨魚投資者一直在瞄準默沙東的價格區間爲50.0美元至115.0美元。
Insights into Volume & Open Interest
成交量和持倉量分析
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Merck & Co's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Merck & Co's significant trades, within a strike price range of $50.0 to $115.0, over the past month.
檢查成交量和未平倉合約可以爲股票研究提供重要的見解。這些信息對於評估默沙東的期權在特定行權價格的流動性和興趣水平至關重要。下面,我們提供了過去一個月內,默沙東重要交易的看漲和看跌期權的成交量和未平倉合約的趨勢快照,行權價格範圍爲50.0美元至115.0美元。
Merck & Co Option Activity Analysis: Last 30 Days
默沙東期權活動分析:過去30天
Largest Options Trades Observed:
觀察到的最大期權交易:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
MRK | CALL | TRADE | BULLISH | 12/19/25 | $14.4 | $13.95 | $14.3 | $95.00 | $173.0K | 219 | 121 |
MRK | CALL | SWEEP | NEUTRAL | 01/16/26 | $14.05 | $13.1 | $13.6 | $95.00 | $54.5K | 420 | 40 |
MRK | CALL | TRADE | BEARISH | 07/18/25 | $3.25 | $2.62 | $2.87 | $115.00 | $43.0K | 131 | 177 |
MRK | CALL | SWEEP | BEARISH | 04/17/25 | $2.12 | $2.07 | $2.08 | $110.00 | $41.6K | 5.8K | 22 |
MRK | CALL | TRADE | BEARISH | 02/21/25 | $9.15 | $8.95 | $9.03 | $95.00 | $36.1K | 500 | 47 |
標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 行權價 | 總交易價格 | 未平倉合約 | 成交量 |
---|---|---|---|---|---|---|---|---|---|---|---|
MRK | 看漲 | 交易 | 看好 | 12/19/25 | $14.4 | $13.95 | $14.3 | $95.00 | 173,000美元 | 219 | 121 |
MRK | 看漲 | 掃單 | 中立 | 01/16/26 | $14.05 | $13.1 | $13.6 | $95.00 | $54.5K | 420 | 40 |
MRK | 看漲 | 交易 | 看淡 | 07/18/25 | $3.25 | $2.62 | $2.87 | $115.00 | $43.0K | 131 | 177 |
MRK | 看漲 | 掃單 | 看淡 | 04/17/25 | $2.12 | $2.07 | $2.08 | $110.00 | 41.6千美元 | 5.8K | 22 |
MRK | 看漲 | 交易 | 看淡 | 02/21/25 | $9.15 | $8.95 | $9.03 | $95.00 | $36.1K | 500 | 47 |
About Merck & Co
關於默沙東
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
默沙東生產藥品,用於治療多種疾病,涵蓋多個治療領域,包括心血管代謝疾病、癌症和感染。在癌症領域,該公司的免疫腫瘤學平台正在成爲整體銷售的重要貢獻者。公司還有一項可觀的生物-疫苗業務,提供預防兒童疾病以及人乳頭瘤病毒(HPV)的治療。此外,默沙東還銷售動物健康相關藥物。從地理角度來看,公司近一半的銷售額來自美國。
Where Is Merck & Co Standing Right Now?
默沙東目前的狀況如何?
- Currently trading with a volume of 5,413,468, the MRK's price is up by 1.57%, now at $101.29.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 28 days.
- 當前的成交量爲5,413,468,MRK的價格上漲1.57%,現爲$101.29。
- RSI讀數表明該股票目前可能接近超買狀態。
- 預計業績將在28天后發佈。
Expert Opinions on Merck & Co
默沙東專家意見
2 market experts have recently issued ratings for this stock, with a consensus target price of $113.0.
最近有2位市場專家對該股票進行了評級,平均目標價爲113.0美元。
Unusual Options Activity Detected: Smart Money on the Move
檢測到期權異動:聰明資金正在行動
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.* An analyst from BMO Capital downgraded its action to Market Perform with a price target of $105. * In a cautious move, an analyst from B of A Securities downgraded its rating to Buy, setting a price target of $121.
Benzinga Edge的期權異動板塊在市場變化發生之前發現潛在的市場動向。查看大資金在您喜歡的股票上採取了什麼頭寸。點擊這裏進行訪問。* BMO資本的一位分析師將其評級下調至市場表現,目標價爲105美元。* 一位來自美銀證券的分析師謹慎地將其評級下調至買入,設定目標價爲121美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Merck & Co with Benzinga Pro for real-time alerts.
交易期權涉及更大的風險,但也提供了更高利潤的潛力。精明的交易者通過持續的教育、戰略交易調整、利用各種因數以及關注市場動態來降低這些風險。通過Benzinga Pro獲取默沙東的最新期權交易,以獲取實時提醒。
譯文內容由第三人軟體翻譯。